Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal AST-726 Treatment for Prophylaxis of Migraine: A Placebo-Controlled Clinical Study

NCT00285402 is registered in ClinicalTrials.gov with Ariston Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00285402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00285402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal AST-726 Treatment for Prophylaxis of Migraine: A Placebo-Controlled Clinical Study
Lead sponsor
Ariston Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2007
Completion date
June 30, 2008
Enrollment
198 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, migraine disorders, migraine headache, migraine with aura, migraine without aura